Optical, real-time monitoring of the glomerular filtration rate

Applied Optics

Volumn 44, Issue 28, 2005, Pages 5956-5965

  Rabito, Carlos A ^a,b   Chen, Yang ^a,b   Schomacker, Kevin T ^a,b   Modell, Mark D ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Radiology ^*

^c DiametRx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; FILTRATION; FLUORESCENCE; SAFETY FACTOR;

REAL-TIME MONITORING; RENAL DISEASES; RENAL FUNCTIONS;

REAL TIME SYSTEMS;

ANIMAL; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SYSTEM; EQUIPMENT; EQUIPMENT DESIGN; EVALUATION; FIBER OPTICS; FLUORESCENCE MICROSCOPY; GLOMERULUS FILTRATION RATE; INSTRUMENTATION; METHODOLOGY; PHYSIOLOGY; RAT; SPECTROFLUOROMETRY; VALIDATION STUDY;

ANIMALS; COMPUTER SYSTEMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FIBER OPTICS; GLOMERULAR FILTRATION RATE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICROSCOPY, FLUORESCENCE; RATS; SPECTROMETRY, FLUORESCENCE;

EID: 28044442936     PISSN: 1559128X     EISSN: 15394522     Source Type: Journal    
DOI: 10.1364/AO.44.005956     Document Type: Article

References (36)

1. U.S. Renal Data System, USRDS Annual Report (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md., 2003).
2. T. Hostetter, "Creatinine assay and reporting estimated GFR," National Kidney Disease Education Program (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md., 2003).
3. A. S. Levey Nephrology Forum, "Measurement of renal function in chronic renal disease," Kidney Int. 38, 167-184 (1990).
4. G. M. Chertow, "Clinical crossroads. A 43-year-old woman with chronic renal insufficiency," J. Am. Med. Assoc. 291, 1252-1259 (2004).
5. H. W. Smith, "Measurement of the filtration rate," in The Kidney: Structure and Function in Health and Disease (Oxford University, 1951), pp. 39-62.
6. B. J. Carrie, H. V. Golbertz, A. S. Michaels, and B. D. Myers, "Creatinine: an inadequate filtration marker in glomerular disease," Am. J. Med. 69, 177-182 (1980).
7. O. Shemesh, H. Golbertz, J. P. Kriss, and B. D. Meyers, "Limitations of creatinine as a filtration marker in glomerulopathic patients," Kidney Int. 28, 830-838 (1985).
8. M. Walser, H. H. Drew, and N. D. LaFrance, "Creatinine measurements often yield false estimates of progression in chronic renal failure," Kidney Int. 34, 412-418 (1988).
9. D. W. Cockcroft and M. H. Gault, "Prediction of creatinine clearance from serum creatinine," Nephron 16, 31-41 (1976).
10. P. J. Swedko, H. D. Clark, K. Paramsothy, and A. Akbari, "Serum creatinine is an inadequate screening test for renal failure in elderly patients," Arch. Intern. Med. 163, 356-360 (2003).
11. D. S. Sherman, D. N. Fish, and I. Teitelbaum, "Assessing renal function in cirrhotic patients: problem and pitfalls," Am. J. Kidney Dis. 41, 269-278 (2003).
12. J. C. Verhave, R. T. Gasenvoort, H. L. Hillege, D. De Zeeuw, G. C. Curhan, and P. E. De Jong for the PREVEND study group, "Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function," J. Am. Soc. Nephrol. 15, 1316-1322 (2004).
13. B. D. Stacy and G. D. Thorburn, "Chromium-51 ethylenediaminetetra acetate for the estimation of the glomerular filtration rate," Science 152, 1076-1078 (1966).
14. R. C. Reba, F. Hosain, and H. N. Wagner, "Indium-113m diethylenetri-aminepentaacetic acid (DTPA): a new radiopharmaceutical for study of the kidneys," Radiology 90, 147-152 (1968).
15. F. Hosain, R. C. Reba, and H. N. Wagner, "Measurement of the glomerular filtration rate using chelated ytterbium-169," Int. J. Appl. Radiat. Isot. 20, 517-524 (1969).
16. 99mTc-DTPA, and inulin," Am. J. Kidney Dis. 16, 224-235 (1990).
17. D. E. Butkus, "Persistent high mortality in acute renal failure. Are we asking the right question?" Arch. Intern. Med. 143, 209-212 (1983).
18. G. M. Chertow, "Controversies in CRRT. On the design and analysis of multicenter trials in acute renal failure," Am. J. Kidney Dis. 30, S96-S101 (1997).
19. R. A. Star, "Perspective in renal medicine. Treatment of acute renal failure," Kidney Int. 54, 1817-1831 (1998).
20. C. A. Rabito, R. H. Moore, C. Bougas, and S. C. Drogotakes, "Noninvasive, real-time monitoring of renal function: the ambulatory renal monitor," J. Nucl. Med. 34, 199-207 (1993).
21. A. M. Harvey and R. Malvin, "Comparison of creatinine clearance in the male and the female rat," Am. J. Physiol. 209, 849-852 (1965).
22. J. K. Frisoli, E. G. Tudor, T. J. Flotte, T. Hasan, T. F. Deutsch, and K. T. Schomacker, "Pharmacokinetics of a fluorescent drug using laser-induced fluorescence," Cancer Res. 53, 5854-5961 (1993).
23. D. P. Earle and R. W. Berliner, "A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow," Proc. Soc. Exp. Biol. Med. 62, 262-264 (1946).
24. E. M. Renkin and J. P. Gilmore, "Glomerular filtration," in Handbook of Physiology, Section 8, Renal Physiology, American Physiology Society, ed., J. Orloff and R. Berliner, section eds. (Waverly, 1973), Chap. 9, pp. 185-248.
25. C. A. Chang, "Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide," Invest. Radiol. 28, S21-S27 (1993).
26. J. A. Kaufman, S. C. Geller, and A. C. Waltman, "Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures," Radiology 198, 579-581 (1996).
27. R. Watts, Y. Wang, B. Redd, P. A. Winchester, K. C. Kent, H. L. Bush, and M. R. Prince, "Recessed elliptical-centric view-ordering for contrast-enhanced 3D MR angiography of the carotid arteries," Magn. Reson. Med. 48, 419-424 (2002).
28. J. N. Lorenz and E. A. Gruenstein, "A simple nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin," Am. J. Physiol. 276, F172-F177 (1999).
29. Z. Qi, I. Whitt, A. Mehta, J. Jin, M. Zhao, R. C. Harris, A. B. Fogo, and M. D. Breyer, "Serial determinations of glomerular filtration rate in conscious mice using FITC-inulin clearance," Am. J. Physiol. 286, F590-F596 (2003).
30. E. S. Harpur, D. Worah, P.-A. Hals, E. Holtz, K. Furuhama, and H. Nomura, "Preclinical safety assessment and pharma cokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent," Invest. Radiol. 28, S27-S43 (1993).
31. L. A. Sapirstein, D. C. Vidt, M. J. Mandel, and G. Honusek, "Volumes of distribution and clearances of intravenously injected creatinine in the dog," Am. J. Physiol. 181, 330-336 (1955).
32. D. W. Swinkels, J. C. M. Hendriks, J. Nauta, and M. C. J. W. de Jong," Glomerular filtration rate by single injection inulin clearance: definition of workable protocol for children," Ann. Clin. Biochem. 37, 60-66 (2000).
33. K. Jung, W. Henke, B. D. Schulze, K. Sydow, K. Precht, and S. Klotzek, "Practical approach for determining glomerular filtration rate by single injection inulin clearance," Clin. Chem. 38, 403-407 (1992).
34. G. Marriott, M. Heidecker, E. P. Diamandis, and Y. Yan-Marriott, "Time-resolved delayed luminescence image microscopy using an europium ion chelate complex," Biophys. J. 67, 957-965 (1994).
35. A. M. Peters, I. Gordon, and R. Sixt, "Normalization of glomerular filtration rate in children: body surface area, body weight, or extracellular fluid volume," J. Nucl. Med. 35, 438-444 (1994).
36. A. S. Alving and B. F. Miller, "A practical method for the measurement of glomerular filtration rate," Arch. Intern. Med. 66, 306-318 (1940).